Li Dong Xun, Oh Yu-Kyuong, Lim Soo-Jeong, Kim Jong Oh, Yang Ho Joon, Sung Jung Hoon, Yong Chul Soon, Choi Han-Gon
College of Pharmacy, Yeungnam University, 214-1 Dae-Dong, Gyongsan 712-749, South Korea.
Int J Pharm. 2008 May 1;355(1-2):277-84. doi: 10.1016/j.ijpharm.2007.12.020. Epub 2007 Dec 24.
A poorly water-soluble ibuprofen and ethanol can be encapsulated in gelatin microcapsule by spray-drying technique. To develop a novel ibuprofen-loaded gelatin microcapsule with bioavailability enhancement, the effect of spray-drying conditions, gelatin, ibuprofen and sodium lauryl sulfate on the ibuprofen solubility and the amount of ethanol encapsulated in gelatin microcapsule were investigated. The ibuprofen solubility and amount of encapsulated ethanol increased as inlet temperature and amount of sodium lauryl sulfate increased, reached maximum at 105 degrees C and 0.6%, respectively and after that followed a rapid decrease. Furthermore, they abruptly increased as the amount of gelatin increased, reaching maximum at 4% then remaining almost stable, but the encapsulated ethanol content decreased noticeably. Likewise, the ibuprofen solubility increased as the amount of ibuprofen increased, reaching maximum at 0.5% and beyond that, there was no change in the solubility. However, the encapsulated ethanol content hardly changed irrespective of the amount of ibuprofen. Furthermore, the formula of ibuprofen-loaded gelatin microcapsule at the ratio of gelatin/ibuprofen/sodium lauryl sulfate/water/ethanol of 4/0.5/0.6/30/70 showed ibuprofen solubility of about 290microg/ml and ethanol content of about 160microg/mg. This gelatin microcapsule dramatically increased the initial dissolution rate of ibuprofen compared to ibuprofen powder in pH 1.2 simulated gastric fluid. Moreover, it gave significantly higher initial plasma concentrations, Cmax and AUC of ibuprofen in rats than did ibuprofen powder, indicating that the drug from gelatin microcapsule could be more orally absorbed in rats. Our results suggested that the enhanced oral bioavailability of ibuprofen in the gelatin microcapsule was contributed by the marked increase in the absorption rate of ibuprofen due to the crystallinity change to amorphous form and increase in dissolution rate of ibuprofen in the gelatin microcapsule in rats. Thus, the ibuprofen-loaded gelatin microcapsule developed using spray-drying technique with gelatin would be useful to deliver ibuprofen in a pattern that allows fast absorption in the initial phase, leading to better absorption.
难溶于水的布洛芬和乙醇可通过喷雾干燥技术封装在明胶微囊中。为开发一种具有生物利用度增强功能的新型载布洛芬明胶微囊,研究了喷雾干燥条件、明胶、布洛芬和十二烷基硫酸钠对布洛芬溶解度以及封装在明胶微囊中乙醇量的影响。布洛芬溶解度和封装乙醇量随进口温度和十二烷基硫酸钠量的增加而增加,分别在105℃和0.6%时达到最大值,之后迅速下降。此外,它们随着明胶量的增加而突然增加,在4%时达到最大值,然后几乎保持稳定,但封装乙醇含量显著下降。同样,布洛芬溶解度随着布洛芬量的增加而增加,在0.5%时达到最大值,超过此值后溶解度没有变化。然而,无论布洛芬量如何,封装乙醇含量几乎不变。此外,明胶/布洛芬/十二烷基硫酸钠/水/乙醇比例为4/0.5/0.6/30/70的载布洛芬明胶微囊配方显示,布洛芬溶解度约为290μg/ml,乙醇含量约为160μg/mg。与pH 1.2模拟胃液中的布洛芬粉末相比,这种明胶微囊显著提高了布洛芬的初始溶解速率。此外,与布洛芬粉末相比,它在大鼠体内的布洛芬初始血浆浓度、Cmax和AUC显著更高,表明明胶微囊中药物在大鼠体内的口服吸收更好。我们的结果表明,明胶微囊中布洛芬口服生物利用度的提高是由于布洛芬结晶形态转变为无定形形式导致吸收速率显著增加以及大鼠体内明胶微囊中布洛芬溶解速率增加所致。因此,使用喷雾干燥技术与明胶开发的载布洛芬明胶微囊将有助于以一种能在初始阶段快速吸收从而实现更好吸收的方式递送布洛芬。